“Businesses Must Amortize All Research and Development Expenses” MYTH — The rules have changed. For tax years 2022 through 2024, businesses generally were required to capitalize and amortize specified research and experimental expenditures. Domestic research expenditures generally required five-year amortization. Foreign research expenditures generally required fifteen-year amortization. However, federal tax legislation enacted in 2025 changed the treatment of domestic research expenditures. 💡 What's Different? For tax years beginning after December 31, 2024, IRC Section 174A generally allows businesses to deduct qualifying domestic research and experimental expenditures in the year paid or incurred. Businesses may alternatively elect certain capitalization and amortization methods. Foreign research expenditures generally remain subject to fifteen-year amortization. 📊 Example A technology company incurs: Domestic qualifying R&D expenditures: $200,000 Foreign qualifying R&D expenditures: $50,000 For 2026, the company may generally deduct the $200,000 of qualifying domestic expenditures currently. The $50,000 of foreign research expenditures generally must be capitalized and amortized over fifteen years. ⚠️ Important Distinction The deduction for research expenditures is not the same as the R&D tax credit. The credit has separate eligibility, calculation, and documentation requirements. Also, businesses with unamortized domestic research expenditures from 2022–2024 should review the applicable transition rules. 🎯 Tax-Smart Lesson A tax strategy that was correct two years ago may no longer be the best strategy today. Tax laws change. Your planning should change with them. 💬 Business Owners: Does your company develop software, improve products, or conduct technical research? You may have research expenditures worth reviewing. 📖 Source: IRS Internal Revenue Bulletin 2026-39 — Domestic Research Expenditure Guidance